Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Preoperative Herceptin and Navelbine for Breast Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by Dana-Farber Cancer Institute.
Recruitment status was  Active, not recruiting
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Brigham and Women's Hospital
Information provided by:
Dana-Farber Cancer Institute Identifier:
First received: September 7, 2005
Last updated: October 30, 2009
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2010
  Primary Completion Date: May 2003 (Final data collection date for primary outcome measure)